Investigating the mechanisms of HER2+breast cancer cell redirection

被引：0
|
作者：
Campbell, Caroline J. [1 ]
Booth, Brian W. [1 ]
机构：
[1] Clemson Univ, Clemson, SC USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2536
引用
收藏
页数：2
相关论文
共 50 条
  • [31] HER2+breast cancer treatment and cardiotoxicity: monitoring and management
    Jerusalem, Guy
    Lancellotti, Patrizio
    Kim, Sung-Bae
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (02) : 237 - 250
  • [32] The Hierarchical Modular Structure of HER2+Breast Cancer Network
    Antonio Alcala-Corona, Sergio
    Espinal-Enriquez, Jesus
    de Anda-Jauregui, Guillermo
    Hernandez-Lemus, Enrique
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [33] Breast MRI as a radiomic biomarker of immune response in HER2+breast cancer
    Kennedy, Laura Carpin
    Durenberger, Grace
    Stanton, Sasha E.
    Vinayak, Shaveta
    Dintzis, Suzanne
    Partridge, Savannah
    Gadi, V. K.
    CANCER RESEARCH, 2020, 80 (04)
  • [34] HER2-related biomarkers in HER2+breast cancer patients in Asia Pacific
    Kim, S-B
    Tsang, J.
    Kim, T-Y
    Yap, Y. S.
    Cornelio, G.
    Gong, G.
    Paik, S.
    Lee, S.
    Ng, T-Y
    Park, S.
    Oh, H-S
    Yau, T.
    Lee, S. H.
    Lim, J. H.
    Choi, Y-J
    Lee, E. M.
    Park, K-H
    Do, I-G
    Yeoh, E-M
    Ro, J.
    CANCER RESEARCH, 2013, 73
  • [35] Generation, characterization, and maintenance of trastuzumab-resistant HER2+breast cancer cell lines
    Zazo, Sandra
    Gonzalez-Alonso, Paula
    Martin-Aparicio, Ester
    Chamizo, Cristina
    Cristobal, Ion
    Arpi, Oriol
    Rovira, Ana
    Albanell, Joan
    Eroles, Pilar
    Lluch, Ana
    Madoz-Gurpide, Juan
    Rojo, Federico
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (11): : 2661 - +
  • [36] Surgical management of Stage I TN and HER2+breast cancer
    Mamtani, A.
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Targeting GPCR signaling in HER2+breast cancer suppresses cancer stem cell tumorigenicity and sensitizes HER2-targeted therapies
    Wang, Wei
    Bhargava, Dharmendra
    Ye, Yuan Chao
    Chen, Songhai
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Pruritus related to trastuzumab and pertuzumab in HER2+breast cancer patients
    Gu, Stephanie
    Dusza, Stephen
    Quigley, Elizabeth
    Haliasos, Helen
    Markova, Alina
    Marchetti, Michael
    Moy, Andrea P.
    Dang, Chau
    Modi, Shanu
    Lake, Diana
    Noor, Sarah
    Lacouture, Mario E.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 271 - 280
  • [39] Optimizing combination therapy in a murine model of HER2+breast cancer?
    Lima, Ernesto A. B. F.
    Wyde, Reid A. F.
    Sorace, Anna G.
    Yankeelov, Thomas E.
    COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING, 2022, 402
  • [40] Prognostic factors and outcome of HER2+breast cancer with CNS metastases
    Masci, Giovanna
    Agostinetto, Elisa
    Giordano, Laura
    Bottai, Giulia
    Torrisi, Rosalba
    Losurdo, Agnese
    De Sanctis, Rita
    Navarria, Piera
    Scorsetti, Marta
    Zuradelli, Monica
    de Rose, Fiorenza
    Bello, Lorenzo
    Santoro, Armando
    FUTURE ONCOLOGY, 2020, 16 (07) : 269 - 279
12345